THIS four-bedroomed house in Oxton is described as 'magnificent'. Situated on Palm Hill, the semi-detached property has, according to the seller, been 'refurbished and presented to a high standard ...

Low Nook Cottage is not only a beautiful family home but one which, thanks to its elevated position, enjoys far-reaching views over ...

Set in a secure, central development, the apartment is close to Dublin Castle, St. Stephen’s Green, Grafton Street and Temple ...

ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest ...

Journal Editorial Report: Paul Gigot interviews Bjorn Lomborg. Electricity prices have jumped 6% nationwide over the last year, about twice as much as overall inflation. They’re now becoming a ...

Newly released data from Realtor.com for July shows that potential buyers and sellers in Washington County saw higher home sale prices than the previous month's median of $299,950. The median home ...

President Trump’s strategy to lower prescription drug prices will be put to the test as drugmakers must now commit to the terms of his “Most Favored Nation” pricing plan or face unspecified actions ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

Asus and Microsoft have finally revealed pricing for the ROG Xbox Ally and Ally X ahead of their global October 16 launch. As part of Xbox’s big presence at the Tokyo Game Show, the companies have ...

President Donald Trump announced on Tuesday a drug pricing deal with Pfizer that will see the pharmaceutical giant lower the cost of its medications for Americans. Trump made the announcement from the ...

President Donald Trump has struck a multi-pronged deal with pharmaceutical giant Pfizer to lower the price of some of the company’s medicines, while clearing a path for the drugmaker to receive a ...